BackTranschem Limited Overview

Transchem Limited EBIT

Transchem Limited's EBIT is $-46M, below the sector sector average of $2.3T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$12.65M
↓ 235.85% YoY

As of Sep 30, 2026

Annual EBIT (TTM)

-$46.42M
↓ 330.06% YoY

Trailing 12 months ending Sep 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Transchem Limited (TRANSCHEM.BO) FAQ

The latest EBIT for TRANSCHEM.BO is $-46M as of September 2026. That compares with $20M in the prior-year period — down 330.1% year over year. That is below the sector sector average of $2.3T. Investors often review this figure alongside Transchem Limited's historical trend and sector peers before judging valuation or financial health.

Over the past year, TRANSCHEM.BO's EBIT moved from $20M to $-46M — a 330.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Transchem Limited's operating scale or balance-sheet position.

Against its sector companies, TRANSCHEM.BO currently prints $-46M for EBIT, while the sector average sits near $2.3T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Transchem Limited's growth, margins, and balance sheet.

A EBIT figure of $-46M for TRANSCHEM.BO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.3T. Explore the charts below for those layers of context.

After noting TRANSCHEM.BO's EBIT ($-46M), review year-over-year change from $20M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

Questions & Answers